Exploring the Brain, One Neuron at a Time

Scientists have discovered that Alzheimer's disease disrupts the 3D organization of DNA in brain cells, fundamentally altering how crucial genes are activated. This previously hidden genomic layer could revolutionize our understanding of the disease and unlock entirely new therapeutic approaches.

A massive analysis of 1.9 million people reveals that ADHD sufferers face dramatically higher rates of digestive disorders—nearly double the constipation risk and four times the odds of encopresis. This striking connection suggests the gut-brain axis plays a more central role in ADHD than previously appreciated.

MIT researchers have developed injectable nanoantennas that can be wirelessly activated to selectively destroy drug-resistant glioblastoma cells while sparing healthy tissue. This targeted nanotechnology approach offers hope for treating one of the most aggressive and notoriously difficult brain cancers.

Semaglutide, the active ingredient in Ozempic and Wegovy, slashed psychiatric hospitalizations by 21% in a Swedish study of nearly 15,000 bipolar disorder patients. The drug's anti-inflammatory effects and influence on brain pathways suggest GLP-1 medications could offer unexpected mental health benefits beyond weight management.